Teva Pharmaceutical Industries (TEVA)
(Delayed Data from NYSE)
$16.76 USD
-0.12 (-0.71%)
Updated May 23, 2024 04:00 PM ET
After-Market: $16.76 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth B Momentum B VGM
Brokerage Reports
0 items in cart
Teva Pharmaceutical Industries Ltd. [TEVA]
Reports for Purchase
Showing records 421 - 440 ( 455 total )
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Slew of new product launches likely to drive overall strong performance in CY12
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Slew of new product launches likely to drive overall strong performance in CY12..
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Near-term outlook remains bleak due to lack of FTF launches & delay in launch of an ‘undisclosed product’...
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Moderately revising downwards our CY11 estimates in view of dismal Q2CY11 performance
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Short term outlook remains bleak in view of ongoing manufacturing issues
Provider: FIRST GLOBAL
Analyst: THOMAS K